Toujeo® Demonstrates a More Stable Profile and Lower Within-day Variability Compared to Insulin Degludec
Paris (ots/PRNewswire) - Further comparative data expected from ongoing head-to-head clinical trial Sanofi (http://www.sanofi.com) announced today the key results of a new pharmacokinetic / pharmacodynamic (PK/PD) study in people with type 1 diabetes comparing Toujeo® (insulin glargine 300 Units/mL) to insulin ...